TDMS Study 88133-06 Pathology Tables
NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02 EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39 TEST TYPE: SUBCHRON 26-WEEK PAGE: 1 CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5 ------------------------------------------------------------------------------------------------------------------------------------ Final#3 REASONS FOR REMOVAL: ALL REMOVAL DATE RANGE: ALL TREATMENT GROUPS: INCLUDE 001 0 MG/KG INCLUDE 002 0 MG/KG INCLUDE 003 0.75 MG/KG INCLUDE 004 0.75 MG/KG INCLUDE 005 1.5 MG/KG INCLUDE 006 1.5 MG/KG INCLUDE 007 3 MG/KG INCLUDE 008 3 MG/KG INCLUDE 009 6 MG/KG INCLUDE 010 6 MG/KG INCLUDE 011 12 MG/KG INCLUDE 012 12 MG/KG NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02 EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39 TEST TYPE: SUBCHRON 26-WEEK CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5 Mice(TG.AC HETEROZYGOUS TRANSGENIC) ----------------------------- FOR ALL DOSES THE TUMOR RATES IN THE FOLLOWING TISSUES/ORGANS ARE BASED ON NUMBER OF TISSUES EXAMINED. IN OTHER TISSUES/ORGANS RATES ARE BASED ON THE NUMBER OF ANIMALS NECROPSIED. --------------- Lung Salivary Glands NTP STATISTICAL ANALYSIS OF PRIMARY TUMORS REPORT: PEIRPT08 LAB: Battelle Columbus TRIMETHYLOLPROPANE TRIACRYLATE DATE: 10/30/02 EXPERIMENT: 88133 TEST: 06 TIME: 10:08:39 TEST TYPE: SUBCHRON 26-WEEK CONT: NO1-ES-65406 ROUTE: SKIN APPLICATION NTP C#: 88133B PATHOLOGIST: TOFT, JOHN CAS: 15625-89-5 SUMMARY OF STATISTICALLY SIGNIFICANT (P